DIRECTOR
Dr. Cannon is currently the founder, President and CEO of NovAb, Inc., which is developing a novel class of antibody biotherapeutics. He was formerly the President and CEO of Unigen Pharmaceuticals, the CEO of AerovectRx, the President and CEO of AdipoGenix; the founding CEO of Elixir Pharmaceuticals; a founder, director, and President of the Therapeutics Division of DyaxCorp and a founder, director and CSO of Hygeia Sciences. Ed earned his Ph.D. in biochemistry from the University of Georgia, trained in molecular immunology at Harvard Medical School and has held faculty positions at Brandeis University and University of Massachusetts Medical School.
